Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jay Venkatesan currently holds 15,250 shares of Angion Biomedica Corp. (ANGN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jay Venkatesan has been a net buyer of ANGN stock. They have purchased $10.1M and sold $8.9M worth of shares.
Jay Venkatesan's most recent insider trade was on Jun 17, 2026, when they sold 96,525 shares at $2.25 per share.
Jay Venkatesan serves as Executive at Angion Biomedica Corp. (ANGN). They have executed 56 insider transactions totaling $19.0M over their tenure at the company.
Jay Venkatesan holds the position of Executive at Angion Biomedica Corp., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Jay Venkatesan has shown a buying trading pattern, with $10.1M in total purchases and $8.9M in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Jay Venkatesan was on Sep 17, 2021, when they sold $3.8M worth of ALPN shares. This transaction involved 400,000 shares at $9.40 per share.
Jay Venkatesan currently owns 15,250 shares of Angion Biomedica Corp. (ANGN), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jay Venkatesan's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jay Venkatesan has 56 Form 4 filings on record as an insider at Angion Biomedica Corp..
Set alerts for Jay Venkatesan and 40,000+ other insiders.